United States Nephrology and Urology Devices Market Outlook to 2033 – Renal Dialysis Equipment and Urinary Tract Stents

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$5995
Buy Report

Published: March 12, 2025 Report Code: GDME0761MDB-ST

Select Item

GlobalData’s “United States Nephrology and Urology Devices Market Outlook to 2033” is a comprehensive databook report, covering key market data on the United States Nephrology and Urology Devices market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Renal Dialysis Equipment and Urinary Tract Stents

The United States Nephrology and Urology Devices Market report provides key information and data on:
• Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
• 2023 company share and distribution share data for Nephrology and Urology Devices Market.
• Global corporate-level profiles of key companies operating within the United States Nephrology and Urology Devices Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

United States Nephrology and Urology Devices is segmented as follows:

• Renal Dialysis Equipment

• Urinary Tract Stents

Reasons to Buy

Key Reasons to Purchase – The United States Nephrology and Urology Devices Market report helps you to develop:

• Business strategies by identifying the key market segments poised for strong growth in the future.

• Market-entry and market expansion strategies.

• Design competition strategies by identifying who-stands-where in the market.

• Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

• Understand the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Key companies covered in the “United States Nephrology and Urology Devices Market Outlook to 2033” report:
• Fresenius Medical Care AG & Co KGaA
• Baxter International Inc
• Boston Scientific Corp
• Nipro Corp
• B. Braun Melsungen AG
• Becton Dickinson and Co
• Cook Group Inc
• Asahi Kasei Corp
• Medtronic Plc
• Outset Medical Inc
• W. L. Gore & Associates Inc
• Toray Industries Inc
• Olympus Corp

Table of Contents

|1 Table of Contents 3

|1.1 List of Tables 7

|1.2 List of Figures 7

2 Introduction 9

2.1 What Is This Report About? 9

2.2 Nephrology and Urology Devices Market Segmentation 9

3 Nephrology and Urology Devices Market, United States 15

3.1 Nephrology and Urology Devices Market, United States, Revenue ($m), 2018-2033 15

3.2 Nephrology and Urology Devices Market, United States, Revenue Mix ($m), 2023 17

3.3 Nephrology and Urology Devices Market, United States, Category Contribution by Revenue ($m), 2023 18

3.4 Nephrology and Urology Devices Market, United States, Revenue ($m), 2018-2033 19

3.5 Nephrology and Urology Devices Market, United States, Volume (Units), 2018-2033 21

3.6 Nephrology and Urology Devices Market, United States, Volume (Units), 2018-2033 23

3.7 Nephrology and Urology Devices Market, United States, Company Share by Revenue ($m), 2023 26

4 Renal Dialysis Equipment Market, United States 28

4.1 Renal Dialysis Equipment Market, United States, Revenue Mix ($m), 2023 28

4.2 Renal Dialysis Equipment Market, United States, Segment Contribution (%), 2023 29

4.3 Renal Dialysis Equipment Market, United States, Revenue ($m), 2018-2033 30

4.3.1 Dialysis Accessories Market, United States, Revenue ($m), by Segment, 2018-2033 32

4.3.2 Dialysis Machines Market, United States, Revenue ($m), by Segment, 2018-2033 34

4.3.3 Stone Management Disposables Market, United States, Revenue ($m), by Segment, 2018-2033 36

4.3.4 Vascular Access Devices for Hemodialysis Market, United States, Revenue ($m), by Segment, 2018-2033 38

4.4 Renal Dialysis Equipment Market, United States, Volume (Units), 2018-2033 40

4.4.1 Dialysis Accessories Market, United States, Volume (Units), by Segment, 2018-2033 42

4.4.2 Dialysis Machines Market, United States, Volume (Units), by Segment, 2018-2033 45

4.4.3 Stone Management Disposables Market, United States, Volume (Units), by Segment, 2018-2033 47

4.4.4 Vascular Access Devices for Hemodialysis Market, United States, Volume (Units), by Segment, 2018-2033 49

4.5 Renal Dialysis Equipment Market, United States, Average Price ($) , 2018-2033 51

4.6 Renal Dialysis Equipment Market, United States, Distribution Share by Revenue ($m), 2023 54

4.7 Renal Dialysis Equipment Market, United States, Company Share by Revenue ($m), 2023 55

5 Urinary Tract Stents Market, United States 57

5.1 Urinary Tract Stents Market, United States, Revenue Mix ($m), 2023 57

5.2 Urinary Tract Stents Market, United States, Segment Contribution (%), 2023 58

5.3 Urinary Tract Stents Market, United States, Revenue ($m), 2018-2033 59

5.3.1 Prostate Stents Market, United States, Revenue ($m), by Segment, 2018-2033 61

5.3.2 Ureteral Stents Market, United States, Revenue ($m), by Segment, 2018-2033 63

5.3.3 Urethral Stents Market, United States, Revenue ($m), by Segment, 2018-2033 65

5.4 Urinary Tract Stents Market, United States, Volume (Units), 2018-2033 67

5.4.1 Prostate Stents Market, United States, Volume (Units), by Segment, 2018-2033 69

5.4.2 Ureteral Stents Market, United States, Volume (Units), by Segment, 2018-2033 71

5.4.3 Urethral Stents Market, United States, Volume (Units), by Segment, 2018-2033 73

5.5 Urinary Tract Stents Market, United States, Average Price ($) , 2018-2033 75

5.6 Urinary Tract Stents Market, United States, Distribution Share by Revenue ($m), 2023 76

5.7 Urinary Tract Stents Market, United States, Company Share by Revenue ($m), 2023 77

6 Overview of Key Companies in United States, Nephrology and Urology Devices Market 79

6.1 Boston Scientific Corp 79

6.1.1 Company Overview 79

6.2 Fresenius Medical Care AG & Co KGaA 79

6.2.1 Company Overview 79

6.3 Cook Group Inc 79

6.3.1 Company Overview 79

6.4 Baxter International Inc 79

6.4.1 Company Overview 79

6.5 Becton Dickinson and Co 80

6.5.1 Company Overview 80

6.6 Nipro Corp 80

6.6.1 Company Overview 80

6.7 B. Braun Melsungen AG 80

6.7.1 Company Overview 80

6.8 Asahi Kasei Corp 80

6.8.1 Company Overview 80

7 Nephrology and Urology Devices Market Pipeline Products 81

8 Financial Deals Landscape 84

8.1 Acquisition 84

8.1.1 Hologic Acquires Gynesonics for Approximately USD350 Million 84

8.1.2 Smiths Group Sells

4.9% Stake in ICU Medical For USD152 Million 86

8.1.3 Smiths Group Sells

3.44% Stake in ICU Medical for USD88 Million 88

8.2 Asset Transactions 89

8.2.1 Carlyle Group to Acquire Vantive Kidney Care Segment from Baxter for USD3.8 Billion 89

8.3 Debt Offerings 91

8.3.1 Stryker Raises USD883.83 Million Public Offering of

3.375% Notes Due 2032 91

8.3.2 Stryker Raises USD662.87 Million in Public Offering of

3.625% Notes Due 2036 93

9 Recent Developments 94

9.1 Corporate Communications 94

9.1.1 Oct 25, 2024: Sonavex secures $15m in Series A-2 funding round 94

9.1.2 Oct 18, 2024: CVS Health Appoints David Joyner President and Chief Executive Officer 94

9.1.3 Oct 17, 2024: AdaptHealth Appoints Diana Nole to Board of Directors 96

9.1.4 Sep 24, 2024: Inspira Launches INSPIRA ART100 at the World's Largest Extracorporeal Life Support Conference 96

9.1.5 Sep 13, 2024: DaVita Names David Maughan as Chief Operating Officer 97

9.1.6 Aug 27, 2024: RQM+ Announces Leadership Appointments 97

9.1.7 May 31, 2024: Children’s Hospital of Philadelphia Appoints New Chief of Gastroenterology, Hepatology and Nutrition 97

9.1.8 Apr 18, 2024: American Society of Nephrology Calls on Congress to Increase Funding for the US Transplant System 98

9.1.9 Apr 04, 2024: PROCEPT BioRobotics Announces Investor Event at 2024 AUA Annual Meeting in San Antonio, Texas 99

9.2 Financial Announcements 99

9.2.1 Dec 19, 2024: AngioDynamics to Report Fiscal 2025 Second Quarter Financial Results on January 8, 2025 and Host Virtual NanoKnife Investor Event 99

9.2.2 Dec 18, 2024: Jabil Announces Financial Results for Q1 of Fiscal Year 2025 99

9.2.3 Dec 12, 2024: GE HealthCare to Announce Fourth Quarter and Full Year 2024 Results on February 13, 2025 100

9.2.4 Dec 05, 2024: CooperCompanies Releases Q4 and Full Year 2024 Financial Results 100

9.2.5 Nov 13, 2024: Aethlon Medical Reports Results for Fiscal Q2 Ended September 30, 2024 and Announces Corporate Update 101

9.2.6 Nov 07, 2024: Nephros Announces Financial Results for Quarter Ended September 30, 2024 102

9.2.7 Oct 31, 2024: Immunic to Announce Financial Results for the Third Quarter Ended September 30, 2024, and Provide Corporate Update 103

9.2.8 Oct 28, 2024: ICU Medical Announces Time of Third Quarter 2024 Earnings Conference Call 104

9.2.9 Oct 23, 2024: Boston Scientific Reports Results for Q3 2024 104

9.2.10 Oct 21, 2024: Owens & Minor Announces Third Quarter 2024 Earnings Release Date and Conference Call 105

9.2.11 Oct 16, 2024: Baxter to Host Third-Quarter 2024 Financial Results Conference Call for Investors 105

9.2.12 Oct 14, 2024: Rockwell Medical to Release Third Quarter 2024 Results on Monday, November 11, 2024 105

9.2.13 Oct 09, 2024: DaVita Schedules 3rd Quarter 2024 Investor Conference Call 106

9.2.14 Oct 08, 2024: Merit Medical Systems to Announce Third Quarter 2024 Results on October 30, 2024 106

9.2.15 Oct 03, 2024: AngioDynamics Announces Fiscal Year 2025 Q1 Results 106

9.2.16 Oct 02, 2024: Boston Scientific Announces Conference Call Discussing Third Quarter 2024 Results 108

9.2.17 Oct 01, 2024: Stryker to Announce Its Third Quarter 2024 Financial Results 108

9.2.18 Sep 26, 2024: Jabil Announces Q4 and Fiscal Year 2024 Results 108

9.2.19 Aug 06, 2024: Aethlon Medical to Release Fiscal First Quarter Financial Results and Host Conference Call on August 14, 2024 110

9.2.20 Aug 01, 2024: Nephros Schedules Second Quarter 2024 Financial Results Conference Call 110

9.2.21 Aug 01, 2024: Merit Medical Systems Announces Q2 2024 Results and Raises Full-Year Guidance 111

9.2.22 Jul 24, 2024: ICU Medical Announces Time of Second Quarter 2024 Earnings Conference Call 112

9.2.23 Jul 17, 2024: Baxter to Host Second-Quarter 2024 Financial Results Conference Call for Investors 112

9.2.24 Jul 01, 2024: Stryker to Announce Financial Results for its Second Quarter of Fiscal Year 2024 112

9.2.25 Jun 21, 2024: Aethlon Medical to Release Fiscal Year End Financial Results and Host Conference Call on June 27, 2024 112

9.2.26 Jun 18, 2024: Merit Medical Systems to Announce Second Quarter 2024 Results on August 1, 2024 113

9.2.27 Jun 04, 2024: Johnson & Johnson to Host Investor Conference Call on Second-Quarter Results 113

9.2.28 Apr 23, 2024: ICU Medical Announces Time of First Quarter 2024 Earnings Conference Call 113

9.2.29 Apr 17, 2024: DaVita Schedules 1st Quarter 2024 Investor Conference Call 113

9.2.30 Feb 22, 2024: Zynex Sets Fourth Quarter and Full Year 2023 Earnings Call 114

9.2.31 Feb 08, 2024: Teleflex Announces Fourth Quarter 2023 Earnings Conference Call Information 114

9.3 Government and Public Interest 114

9.3.1 Dec 19, 2024: AngioDynamics to Report Fiscal 2025 Second Quarter Financial Results on January 8, 2025 and Host Virtual NanoKnife Investor Event 114

9.3.2 Oct 04, 2024: Johnson & Johnson to Participate in the Guggenheim Global Healthcare Conference 115

9.3.3 May 28, 2024: Immunic to Participate in Industry and Scientific Conferences in June 115

9.3.4 May 21, 2024: FDA Provides Clearance to IND Application for Type 1 Diabetes Therapy SAB-142 by SAB Biotherapeutics 115

9.3.5 May 07, 2024: Baxter to Present at Bank of America 2024 Health Care Conference 116

9.3.6 Apr 24, 2024: Merus Announces Presentation MCLA-129 at the 2024 ASCO Annual Meeting 116

9.3.7 Apr 22, 2024: Johnson & Johnson to Participate in the Bernstein’s 40th Annual Strategic Decisions Conference (SDC) 117

9.3.8 Apr 11, 2024: Oncolytics Biotech Advances toward Registration-Enabling Trial for Pelareorep in Breast Cancer with Submission of Type C Meeting Request to FDA 117

9.3.9 Apr 02, 2024: Johnson & Johnson to Participate in the BofA Securities Health Care Conference 118

9.3.10 Mar 05, 2024: Sigyn Therapeutics Announces CEO Presentation at Upcoming Emerging Growth Conference 119

9.3.11 Feb 28, 2024: Access Vascular Supports Updated Standards of Care Emphasizing New Materials to Reduce Catheter Complications 119

9.3.12 Feb 23, 2024: Edwards Lifesciences to Present at the 44th Annual TD Cowen Healthcare Conference 119

9.3.13 Feb 14, 2024: GE HealthCare Management to Present at Upcoming Investor Conferences 120

9.3.14 Feb 14, 2024: Johnson & Johnson to Participate in the Barclays 26th Annual Global Healthcare Conference 120

9.4 Legal And Regulatory 120

9.4.1 Dec 08, 2024: Shenzhen Smallsignal Technology Receives 510(K) Clearance For Fingertip Pulse Oximeter – Model Alpine 120

9.4.2 Oct 10, 2024: FDA Grants iota Biosciences IDE Approval for First-In-Human Early Feasibility Study with Implantable Bladder Device 120

9.4.3 Sep 05, 2024: InBios Receives FDA 510(k) Clearance for COVID-19 POC Antigen Detection Test 121

9.4.4 Apr 28, 2024: Becton Dickinson Receives Additional 510(K) Clearance For BD Vacutainer K2EDTA Blood Collection Tube 122

9.4.5 Apr 16, 2024: Leading Global Biotechnology Company Selects ValGenesis iRisk to Advance Its Pipeline of Critical Drug Therapies 122

9.5 Other Significant Developments 123

9.5.1 Jan 13, 2025: Werfen Receives US FDA 510(k) Clearance for Aptiva Antiphospholipid Syndrome Reagents 123

9.5.2 Jan 10, 2025: Fresenius Medical Care Supports Patients and Staff During the Wildfires in Southern California 123

9.5.3 Dec 17, 2024: Rockwell Medical Enters into a Multi-Year Product Purchase Agreement with the World’s Leading Provider of Dialysis Products and Services 124

9.5.4 Oct 11, 2024: Fresenius Medical Care Ramping up Supply of IV Fluids and PD Products Post-Hurricane Helene and Is Ensuring Safety of Patients and Employees in the Face of Hurricane Milton 124

9.5.5 Sep 25, 2024: Siemens Healthineers Announces First U.S. Installation of Ciartic Move Self-Driving Mobile C-arm 125

9.5.6 Sep 12, 2024: HHS Launches $7.25 Million KidneyX Sustainability Prize 126

9.5.7 May 24, 2024: iHealthScreen Developed and Validated Risk Prediction Models for Cardiovascular Diseases Using Individual’s Retinal Color Images and Health Data 126

9.5.8 Apr 16, 2024: Medable Achieves 75% eConsent Adoption Across Elderly Patients in Pivotal U.S. Renal Care Clinical Trial 127

9.5.9 Mar 25, 2024: New tuberculosis partnership in India 127

9.5.10 Mar 05, 2024: Davita Enters into Agreement to Expand Operations in Brazil and Colombia, Enter Chile and Ecuador 128

9.6 Product News 129

9.6.1 Nov 20, 2024: Interwell Health Launches Acumen Rounder 129

9.6.2 Nov 18, 2024: Fresenius Medical Care's AI-Powered Application of the Anemia Control Model Selected for CMS AI Demo Days in the United States 130

9.6.3 Oct 24, 2024: Fresenius Medical Care Recent Study Validates Innovative Anemia Therapy Software Improves Clinical Outcomes for Hemodialysis Patients 130

9.6.4 Oct 21, 2024: Fresenius Medical Care Showcases Research and Innovations in Kidney Care at American Society of Nephrology (ASN) Kidney Week 2024 131

9.6.5 Oct 08, 2024: Uroflo Device Recognized for Potential Urological Care 132

9.6.6 Sep 11, 2024: Merit Medical to Present at the 2024 Cardiovascular and Interventional Radiological Society of Europe (CIRSE) Annual Congress 133

9.6.7 Aug 09, 2024: VISE Team Works to Develop 3D Navigation System to Better Treat Kidney Stones 134

9.6.8 Jun 10, 2024: B. Braun Interventional Systems Launches ACCEL All-Purpose and Biliary Drainage Catheters 134

9.6.9 Jun 07, 2024: Article In Nature Scientific Reports Describes Mechanism Of Action Of Seastar Medical’s Selective Cytopheretic Device In The Immunomodulation Of Excessive Inflammation 135

9.6.10 May 25, 2024: New technique detects novel biomarkers for kidney diseases with nephrotic syndrome 136

9.6.11 May 21, 2024: Fresenius Medical Care showcases leadership and innovation in kidney care disease at 61st European Renal Association (ERA) Congress 2024 136

9.6.12 Mar 18, 2024: Fresenius Kabi and Formycon Reach Settlement Agreement for Ustekinumab Biosimilar Candidate 137

9.6.13 Mar 12, 2024: SeaStar Medical-Sponsored Symposium Featuring Experts Discussing Pediatric Acute Kidney Injury and the Selective Cytopheretic Device to be Webcast Live at AKI & CRRT 2024 138

9.6.14 Mar 05, 2024: Sigyn Therapeutics to Present at Tomorrow’s Emerging Growth Conference 139

9.6.15 Feb 29, 2024: Phase II Clinical Trial Begins for Polycystic Kidney Disease Drug Candidate Identified by IPs Cell-Based Drug Discovery 139

9.7 Strategy And Business Planning 140

9.7.1 Sep 12, 2024: HHS Launches $7.25 Million KidneyX Sustainability Prize 140

9.7.2 Apr 17, 2024: Rockwell Medical Continues to Expand its Distribution Capabilities in Western United States 141

9.7.3 Mar 05, 2024: Davita Enters into Agreement to Expand Operations in Brazil and Colombia, Enter Chile and Ecuador 141

10 Appendix 143

10.1 Research Methodology 144

10.1.1 Coverage 144

10.1.2 Secondary Research 144

10.1.3 Primary Research 145

10.1.4 Market Modeling and Forecasting 146

10.1.5 Company Share Analysis 147

10.1.6 Distribution Share Analysis 147

10.1.7 Benchmarking 148

10.2 GlobalData Consulting 148

10.3 Contact Us 148

10.4 Disclaimer 149

Table

Table 1: Nephrology and Urology Devices Market, United States, Revenue ($m), USD Constant, 2018-2033 16

Table 2: Nephrology and Urology Devices Market, United States, Category Contribution by Revenue ($m), 2023 18

Table 3: Nephrology and Urology Devices Market, United States, Revenue ($m), USD Constant, 2018-2033 20

Table 4: Nephrology and Urology Devices Market, United States, Volume (Units), 2018-2033 22

Table 5: Nephrology and Urology Devices Market, United States, Volume (Units), 2018-2033 25

Table 6: Nephrology and Urology Devices Market, United States, Company Share by Revenue ($m), USD Constant, 2023 27

Table 7: Renal Dialysis Equipment Market, United States, Segment Contribution (%), 2023 29

Table 8: Renal Dialysis Equipment Market, United States, Revenue ($m), USD Constant, 2018-2033 31

Table 9: Dialysis Accessories Market, United States, Revenue ($m), USD Constant, 2018-2033 33

Table 10: Dialysis Machines Market, United States, Revenue ($m), USD Constant, 2018-2033 35

Table 11: Stone Management Disposables Market, United States, Revenue ($m), USD Constant, 2018-2033 37

Table 12: Vascular Access Devices for Hemodialysis Market, United States, Revenue ($m), USD Constant, 2018-2033 39

Table 13: Renal Dialysis Equipment Market, United States, Volume (Units), 2018-2033 41

Table 14: Dialysis Accessories Market, United States, Volume (Units), 2018-2033 43

Table 15: Dialysis Machines Market, United States, Volume (Units), 2018-2033 46

Table 16: Stone Management Disposables Market, United States, Volume (Units), 2018-2033 48

Table 17: Vascular Access Devices for Hemodialysis Market, United States, Volume (Units), 2018-2033 50

Table 18: Renal Dialysis Equipment Market, United States, Average Price ($), 2018-2033 51

Table 19: Renal Dialysis Equipment Market, United States, Distribution Share by Revenue ($m), USD Constant, 2023 54

Table 20: Renal Dialysis Equipment Market, United States, Company Share by Revenue ($m), USD Constant, 2023 56

Table 21: Urinary Tract Stents Market, United States, Segment Contribution (%), 2023 58

Table 22: Urinary Tract Stents Market, United States, Revenue ($m), USD Constant, 2018-2033 60

Table 23: Prostate Stents Market, United States, Revenue ($m), USD Constant, 2018-2033 62

Table 24: Ureteral Stents Market, United States, Revenue ($m), USD Constant, 2018-2033 64

Table 25: Urethral Stents Market, United States, Revenue ($m), USD Constant, 2018-2033 66

Table 26: Urinary Tract Stents Market, United States, Volume (Units), 2018-2033 68

Table 27: Prostate Stents Market, United States, Volume (Units), 2018-2033 70

Table 28: Ureteral Stents Market, United States, Volume (Units), 2018-2033 72

Table 29: Urethral Stents Market, United States, Volume (Units), 2018-2033 74

Table 30: Urinary Tract Stents Market, United States, Average Price ($), 2018-2033 75

Table 31: Urinary Tract Stents Market, United States, Distribution Share by Revenue ($m), USD Constant, 2023 76

Table 32: Urinary Tract Stents Market, United States, Company Share by Revenue ($m), USD Constant, 2023 78

Table 33: Nephrology and Urology Devices Market Pipeline Products 81

Table 34: Hologic Acquires Gynesonics for Approximately USD350 Million 84

Table 35: Smiths Group Sells 4.9% Stake in ICU Medical For USD152 Million 86

Table 36: Smiths Group Sells 3.44% Stake in ICU Medical for USD88 Million 88

Table 37: Carlyle Group to Acquire Vantive Kidney Care Segment from Baxter for USD3.8 Billion 89

Table 38: Stryker Raises USD883.83 Million Public Offering of 3.375% Notes Due 2032 91

Table 39: Stryker Raises USD662.87 Million in Public Offering of 3.625% Notes Due 2036 93

Table 40: Total Number of Primary Research Participants, Nephrology and Urology Devices Market, by Country 145

Figures

Figure 1: Nephrology and Urology Devices Market, United States, Revenue ($m), USD Constant, 2018-2033 15

Figure 2: Nephrology and Urology Devices Market, United States, Revenue Mix ($m), 2023 17

Figure 3: Nephrology and Urology Devices Market, United States, Category Contribution (%), 2023 18

Figure 4: Nephrology and Urology Devices Market, United States, Revenue ($m), USD Constant, 2018-2033 19

Figure 5: Nephrology and Urology Devices Market, United States, Volume (Units), 2018-2033 21

Figure 6: Nephrology and Urology Devices Market, United States, Volume (Units), 2018-2033 23

Figure 7: Nephrology and Urology Devices Market, United States, Company Share (%) 2023 26

Figure 8: Renal Dialysis Equipment Market, United States, Revenue Mix ($m), 2023 28

Figure 9: Renal Dialysis Equipment Market, United States, Segment Contribution (%), 2023 29

Figure 10: Renal Dialysis Equipment Market, United States, Revenue ($m), USD Constant, 2018-2033 30

Figure 11: Dialysis Accessories Market, United States, Revenue ($m), USD Constant, 2018-2033 32

Figure 12: Dialysis Machines Market, United States, Revenue ($m), USD Constant, 2018-2033 34

Figure 13: Stone Management Disposables Market, United States, Revenue ($m), USD Constant, 2018-2033 36

Figure 14: Vascular Access Devices for Hemodialysis Market, United States, Revenue ($m), USD Constant, 2018-2033 38

Figure 15: Renal Dialysis Equipment Market, United States, Volume (Units), 2018-2033 40

Figure 16: Dialysis Accessories Market, United States, Volume (Units), 2018-2033 42

Figure 17: Dialysis Machines Market, United States, Volume (Units), 2018-2033 45

Figure 18: Stone Management Disposables Market, United States, Volume (Units), 2018-2033 47

Figure 19: Vascular Access Devices for Hemodialysis Market, United States, Volume (Units), 2018-2033 49

Figure 20: Renal Dialysis Equipment Market, United States, Company Share (%) 2023 55

Figure 21: Urinary Tract Stents Market, United States, Revenue Mix ($m), 2023 57

Figure 22: Urinary Tract Stents Market, United States, Segment Contribution (%), 2023 58

Figure 23: Urinary Tract Stents Market, United States, Revenue ($m), USD Constant, 2018-2033 59

Figure 24: Prostate Stents Market, United States, Revenue ($m), USD Constant, 2018-2033 61

Figure 25: Ureteral Stents Market, United States, Revenue ($m), USD Constant, 2018-2033 63

Figure 26: Urethral Stents Market, United States, Revenue ($m), USD Constant, 2018-2033 65

Figure 27: Urinary Tract Stents Market, United States, Volume (Units), 2018-2033 67

Figure 28: Prostate Stents Market, United States, Volume (Units), 2018-2033 69

Figure 29: Ureteral Stents Market, United States, Volume (Units), 2018-2033 71

Figure 30: Urethral Stents Market, United States, Volume (Units), 2018-2033 73

Figure 31: Urinary Tract Stents Market, United States, Company Share (%) 2023 77

United States Nephrology and Urology Devices Market Outlook to 2033 – Renal Dialysis Equipment and Urinary Tract Stents standard reports
Currency USD
$5,995

Can be used by individual purchaser only

Most Popular
$11,990

Can be shared by unlimited users within one corporate location e.g. a regional office

$17,985

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more Nephrology and Urology Devices reports
Medical Devices
New
Global M&A Deals in H1 2026 - Top Themes by…
$495 | August 2026
Medical Devices
New
Medical Devices M&A Deals H1 2026 - Top Themes: Strategic…
$495 | July 2026
Medical Devices
New
AI-designed Materials: Market Trends and Innovations
$995 | July 2026
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at United States Nephrology and Urology Devices Market Outlook to 2033 – Renal Dialysis Equipment and Urinary Tract Stents in real time.

  • Access a live United States Nephrology and Urology Devices Market Outlook to 2033 – Renal Dialysis Equipment and Urinary Tract Stents dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more